NCT07446907

Brief Summary

To test adaptive intensive behavioral therapy strategies comprising dietary patterns with varying amounts of protein and including supplemental protein or resistance exercise training for promoting weight loss and attenuating lean mass loss in adults aged 50-75 with obesity.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
58mo left

Started Sep 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Jun 2031

First Submitted

Initial submission to the registry

February 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2031

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

4.8 years

First QC Date

February 25, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

ObesitySarcopenia

Outcome Measures

Primary Outcomes (2)

  • Change in Body Weight

    Participants will be weighed at baseline through 52 weeks

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • Change in Fat Free Mass

    Participants will be scanned via DXA scan to measure overall fat free body mass

    Baseline, 8 weeks, 16 weeks, 52 weeks

Secondary Outcomes (11)

  • Change in Fat Mass

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • Change in Fasting Glucose

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • Change in Fasting Insulin

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • Change in Fasting Hemoglobin A1C

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • Change in Fasting LDL-cholesterol

    Baseline, 8 weeks, 16 weeks, 52 weeks

  • +6 more secondary outcomes

Study Arms (6)

High Protein Diet Only

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a high protein diet. This arm includes participants identified as responders to the high protein diet counseling in stage 1 at the week 8 assessment.

Behavioral: High Protein Diet Counceling

High Protein Diet + Supplement

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.

Behavioral: High Protein Diet CouncelingBehavioral: Protein Supplement

High Protein Diet + Supervised Exercise

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive supervised resistance training sessions to augment their intervention plan.

Behavioral: High Protein Diet CouncelingBehavioral: Supervised Exercise

Standard Protein Diet Only

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a standard protein diet. This arm includes participants identified as responders to the standard protein diet counseling in stage 1 at the week 8 assessment.

Behavioral: Standard Protein Diet Counceling

Standard Protein Diet + Supplement

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a standard protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.

Behavioral: Standard Protein Diet CouncelingBehavioral: Protein Supplement

Standard Protein Diet + Supervised Exercise

ACTIVE COMPARATOR

Enrollment in State of Slim (SOS) weight loss program with a standard protein diet. Participants identified as non-responders at the week 8 assessment will receive supervised resistance training sessions to augment their intervention plan.

Behavioral: Standard Protein Diet CouncelingBehavioral: Supervised Exercise

Interventions

16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.

High Protein Diet + Supervised ExerciseHigh Protein Diet + SupplementHigh Protein Diet Only

16 week group-based weight loss program with counseling to consume a standard protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 53%:20%:27%.

Standard Protein Diet + Supervised ExerciseStandard Protein Diet + SupplementStandard Protein Diet Only

Non-responders from either initial randomized group assigned to this intervention receive twice daily protein supplements.

High Protein Diet + SupplementStandard Protein Diet + Supplement

Non-responders from either initial randomized group assigned to this intervention receive twice weekly small-group supervised resistance exercise training sessions.

High Protein Diet + Supervised ExerciseStandard Protein Diet + Supervised Exercise

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female sex
  • all racial and ethnic groups
  • BMI: 30-50 kg/m2
  • age 50-75 years
  • postmenopausal status for ≥1 y if female sex

You may not qualify if:

  • \<3 months stable use of other medications affecting body weight or appetite
  • \>450 pounds (due to weight limitations of the DXA)
  • indication or previous diagnosis of sarcopenia
  • existing kidney disease
  • current binge eating disorder, anorexia, or bulimia
  • untreated hyper- or hypothyroidism, cancer (except basal cell), gastrointestinal disorders affecting food intake or nutrient absorption; any other medical condition, as determined by the study physician, precluding a HP diet and/or daily exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

ObesityOverweightSarcopenia

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Study Officials

  • Drew Sayer, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Sequential Multiple Assignment Randomized Trial (SMART)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 25, 2026

First Posted

March 3, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

June 30, 2031

Study Completion (Estimated)

June 30, 2031

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

At the time of publication(s) related to this trial, a fully de-identified dataset including individual participant data will be made available so that data analysis can be replicated by other investigators. This dataset will be freely available for download as supplemental material to manuscript(s) submitted to PubMed Central.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
IPD and supporting information will be available at the time of publication of manuscripts associated with this trial.
Access Criteria
Freely available for download from PubMed Central as supplemental material to associated manuscripts.

Locations